{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:23:11Z","timestamp":1792174991493,"version":"4.4.0"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Although pediatric pheochromocytomas and paragangliomas (PPGLs) are rare, they have important differences compared to those in adults. Unfortunately, without timely diagnosis and management, these tumors have a potentially devastating impact on pediatric patients. Pediatric PPGLs are more often extra-adrenal, multifocal\/metastatic, and recurrent, likely due to these tumors being more commonly due to a genetic predisposition than in adults. This genetic risk results in disease manifestations at an earlier age giving these tumors time to advance before detection. In spite of these problematic features, advances in the molecular and biochemical characterization of PPGLs have heralded an age of increasingly personalized medicine. An understanding of the genetic basis for an individual patient\u2019s tumor provides insight into its natural history and can guide clinicians in management of this challenging disease. In pediatric PPGLs, mutations in genes related to pseudohypoxia are most commonly seen, including the von Hippel-Lindau gene (<jats:italic>VHL<\/jats:italic>) and succinate dehydrogenase subunit (<jats:italic>SDHx<\/jats:italic>) genes, with the highest risk for metastatic disease associated with variants in <jats:italic>SDHB<\/jats:italic> and <jats:italic>SDHA<\/jats:italic>. Such pathogenic variants are associated with a noradrenergic biochemical phenotype with resultant sustained catecholamine release and therefore persistent symptoms. This is in contrast to paroxysmal symptoms (e.g., episodic hypertension, palpitations, and diaphoresis\/flushing) as seen in the adrenergic, or epinephrine-predominant, biochemical phenotype (due to episodic catecholamine release) that is commonly observed in adults. Additionally, PPGLs in children more often present with signs and symptoms of catecholamine excess. Therefore, children, adolescents, and young adults present differently from older adults (e.g., the prototypical presentation of palpitations, perspiration, and pounding headaches in the setting of an isolated adrenal mass). These presentations are a direct result of genetic determinants and highlight the need for pediatricians to recognize these differences in order to expedite appropriate evaluations, including genetic testing. Identification and familiarity with causative genes inform surveillance and treatment strategies to improve outcomes in pediatric patients with PPGL.<\/jats:p>","DOI":"10.3389\/fendo.2022.936178","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T05:27:52Z","timestamp":1657603672000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches"],"prefix":"10.3389","volume":"13","author":[{"given":"Mickey J. M.","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, Diagnosis, Management and Future Directions of Research of Phaeochromocytoma and Paraganglioma: A Position Statement and Consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12495","article-title":"Metastatic Pheochromocytoma and Paraganglioma","volume":"45","author":"Angelousi","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/ERC-13-0415","article-title":"Long-Term Prognosis of Patients With Pediatric Pheochromocytoma","volume":"21","author":"Bausch","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14467","article-title":"Genetic and Clinical Aspects of Paediatric Pheochromocytomas and Paragangliomas","volume":"95","author":"Petenuci","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14222","article-title":"Bilateral Pheochromocytoma: Clinical Characteristics, Treatment and Longitudinal Follow-Up","volume":"93","author":"Kittah","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28981","article-title":"Pseudohypoxic Pheochromocytomas and Paragangliomas Dominate in Children","volume":"68","author":"Redlich","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.610746","article-title":"Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea","volume":"11","author":"Park","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-0888-9","article-title":"Update on Pediatric Pheochromocytoma","volume":"24","author":"Havekes","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2299","article-title":"Pheochromocytoma and Paraganglioma in Children: A Review of Medical and Surgical Management at a Tertiary Care Center","volume":"118","author":"Pham","year":"2006","journal-title":"Pediatrics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in Von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90591.2008","article-title":"Differential Expression of the Regulated Catecholamine Secretory Pathway in Different Hereditary Forms of Pheochromocytoma","volume":"295","author":"Eisenhofer","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative Management of the Pheochromocytoma Patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.080","article-title":"Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week","volume":"76","author":"Nazari","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4158\/EP161718.RA","article-title":"Precision Medicine: An Update on Genotype\/Biochemical Phenotype Relationships in Pheochromocytoma\/Paraganglioma Patients","volume":"23","author":"Gupta","year":"2017","journal-title":"Endocr Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"502734","DOI":"10.1155\/2014\/502734","article-title":"SDHB-Associated Paraganglioma in a Pediatric Patient and Literature Review on Hereditary Pheochromocytoma-Paraganglioma Syndromes","volume":"2014","author":"Choat","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0651","article-title":"Longitudinal Plasma Metanephrines Preceding Pheochromocytoma Diagnosis: A Retrospective Case-Control Serum Repository Study","volume":"174","author":"Olson","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000476","article-title":"Metastatic Pheochromocytoma and Paraganglioma: Recent Advances in Prognosis and Management","volume":"26","author":"Hamidi","year":"2019","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1353.003","article-title":"Characteristics of Pheochromocytoma in a 4- to 20-Year-Old Population","volume":"1073","author":"Barontini","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-020-03138-5","article-title":"Clinical Characteristics and Outcomes of SDHB-Related Pheochromocytoma and Paraganglioma in Children and Adolescents","volume":"146","author":"Jochmanova","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/147323001204000442","article-title":"Primary Paraganglioma of the Lung: A Case Report and Literature Review","volume":"40","author":"Zhang","year":"2012","journal-title":"J Int Med Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e0293","DOI":"10.1097\/MD.0000000000010293","article-title":"Primary Functioning Hepatic Paraganglioma Mimicking Hepatocellular Carcinoma: A Case Report and Literature Review","volume":"97","author":"Liao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized Management of Pheochromocytoma and Paraganglioma","volume":"43","author":"Nolting","year":"2022","journal-title":"Endocr Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of Pheochromocytoma and Sympathetic Paraganglioma in the Netherlands: A Nationwide Study and Systematic Review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3035","article-title":"Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0339","article-title":"Genetics of Pheochromocytoma and Paraganglioma in Spanish Pediatric Patients","volume":"20","author":"Cascon","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1053\/jpsu.2001.21612","article-title":"Pheochromocytoma in Children","volume":"36","author":"Ciftci","year":"2001","journal-title":"J Pediatr Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.surg.2014.08.020","article-title":"Hypoglycemia After Resection of Pheochromocytoma","volume":"156","author":"Chen","year":"2014","journal-title":"Surgery"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2830","article-title":"A Current Review of the Etiology, Diagnosis, and Treatment of Pediatric Pheochromocytoma and Paraganglioma","volume":"95","author":"Waguespack","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.5.8446","article-title":"Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma","volume":"87","author":"Weise","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cca.2018.12.019","article-title":"Reference Intervals for LC-MS\/MS Measurements of Plasma Free, Urinary Free and Urinary Acid-Hydrolyzed Deconjugated Normetanephrine, Metanephrine and Methoxytyramine","volume":"490","author":"Eisenhofer","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma Versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0077","article-title":"Plasma Methoxytyramine: Clinical Utility With Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma","volume":"177","author":"Rao","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma Methoxytyramine: A Novel Biomarker of Metastatic Pheochromocytoma and Paraganglioma in Relation to Established Risk Factors of Tumour Size, Location and SDHB Mutation Status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12245","article-title":"Clinical Utility of Chromogranin A in SDHx-Related Paragangliomas","volume":"44","author":"Zuber","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.5926","article-title":"Metanephrines for Evaluating Palpitations and Flushing","volume":"318","author":"Hannah-Shmouni","year":"2017","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0778","article-title":"Pheochromocytoma Crisis Induced by Glucocorticoids: A Report of Four Cases and Review of the Literature","volume":"158","author":"Rosas","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1055\/a-1526-5263","article-title":"Hypoxia-Inducible Factor 2alpha: A Key Player in Tumorigenesis and Metastasis of Pheochromocytoma and Paraganglioma","volume":"130","author":"Bechmann","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259689","article-title":"Imaging of Pheochromocytoma and Paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3406","article-title":"Targeting NAD(+)\/PARP DNA Repair Pathway as a Novel Therapeutic Approach to SDHB-Mutated Cluster I Pheochromocytoma and Paraganglioma","volume":"24","author":"Pang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"102164","DOI":"10.1016\/j.redox.2021.102164","article-title":"Mitochondrial Iron-Sulfur Clusters: Structure, Function, and an Emerging Role in Vascular Biology","volume":"47","author":"Read","year":"2021","journal-title":"Redox Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3856","article-title":"Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas","volume":"101","author":"Richter","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/jmedgenet-2019-106214","article-title":"Variant Type Is Associated With Disease Characteristics in SDHB, SDHC and SDHD-Linked Phaeochromocytoma-Paraganglioma","volume":"57","author":"Bayley","year":"2020","journal-title":"J Med Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt201","article-title":"Hypoxia-Inducible Factor Signaling in Pheochromocytoma: Turning the Rudder in the Right Direction","volume":"105","author":"Jochmanova","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-021-00492-3","article-title":"International Consensus on Initial Screening and Follow-Up of Asymptomatic SDHx Mutation Carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.6353","article-title":"Metastatic Pheochromocytoma\/Paraganglioma Related to Primary Tumor Development in Childhood or Adolescence: Significant Link to SDHB Mutations","volume":"29","author":"King","year":"2011","journal-title":"J Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13055","article-title":"The Penetrance of Paraganglioma and Pheochromocytoma in SDHB Germline Mutation Carriers","volume":"93","author":"Rijken","year":"2018","journal-title":"Clin Genet"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-104297","article-title":"Risk Assessment of Maternally Inherited SDHD Paraganglioma and Phaeochromocytoma","volume":"54","author":"Burnichon","year":"2017","journal-title":"J Med Genet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2018-105427","article-title":"Bayesian Approach to Determining Penetrance of Pathogenic SDH Variants","volume":"55","author":"Benn","year":"2018","journal-title":"J Med Genet"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2010.175","article-title":"Von Hippel-Lindau Disease: A Clinical and Scientific Review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel-Lindau and Hereditary Pheochromocytoma\/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood","volume":"23","author":"Rednam","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A Gain-of-Function Mutations in Paraganglioma With Polycythemia","volume":"367","author":"Zhuang","year":"2012","journal-title":"N Engl J Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-012-0967-z","article-title":"A Novel EPAS1\/HIF2A Germline Mutation in a Congenital Polycythemia With Paraganglioma","volume":"91","author":"Lorenzo","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1530\/ERC-16-0231","article-title":"Novel Insights Into the Polycythemia-Paraganglioma-Somatostatinoma Syndrome","volume":"23","author":"Darr","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","article-title":"Neurofibromatosis Type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"Von Recklinghausen's Disease and Pheochromocytomas","volume":"162","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0233","article-title":"Interest of Systematic Screening of Pheochromocytoma in Patients With Neurofibromatosis Type 1","volume":"175","author":"Kepenekian","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.17925\/EE.2019.15.2.95","article-title":"Clinical Presentation and Outcomes of Phaeochromocytomas\/Paragangliomas in Neurofibromatosis Type 1","volume":"15","author":"Al-Sharefi","year":"2019","journal-title":"Eur Endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/367380a0","article-title":"Defects in the Kidney and Enteric Nervous System of Mice Lacking the Tyrosine Kinase Receptor Ret","volume":"367","author":"Schuchardt","year":"1994","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4158\/EP13268.RA","article-title":"Genetics, Diagnosis, and Management of Medullary Thyroid Carcinoma and Pheochromocytoma\/Paraganglioma","volume":"20","author":"Moraitis","year":"2014","journal-title":"Endocr Pract"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2017.00155","article-title":"Review of Pediatric Pheochromocytoma and Paraganglioma","volume":"5","author":"Bholah","year":"2017","journal-title":"Front Pediatr"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730110-00004","article-title":"Adverse Drug Reactions in Patients With Phaeochromocytoma: Incidence, Prevention and Management","volume":"30","author":"Eisenhofer","year":"2007","journal-title":"Drug Saf"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-19-0165","article-title":"Molecular Imaging and Radionuclide Therapy of Pheochromocytoma and Paraganglioma in the Era of Genomic Characterization of Disease Subgroups","volume":"26","author":"Taieb","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"B68","article-title":"Current Concepts on the Diagnostic Use of MIBG in Children","volume":"39","author":"Shulkin","year":"1998","journal-title":"J Nucl Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259697","article-title":"Systemic Radiopharmaceutical Therapy of Pheochromocytoma and Paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of (68)Ga-DOTATATE Over (18)F-FDG and Anatomic Imaging in the Detection of Succinate Dehydrogenase Mutation (SDHx )-Related Pheochromocytoma and Paraganglioma in the Pediatric Population","volume":"45","author":"Jha","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.19.22677","article-title":"Whole-Body PET\/MRI Applications in Pediatric Oncology","volume":"215","author":"States","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of (68)Ga-DOTA-Conjugated Somatostatin Receptor-Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis","volume":"60","author":"Han","year":"2019","journal-title":"J Nucl Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26071","article-title":"Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET\/CT Using (68)Ga-DOTATATE, FDG, (18)F-FDOPA, and (18)F-FDA)","volume":"218","author":"Jha","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.106.035915","article-title":"Brown Fat Imaging With (18)F-6-Fluorodopamine PET\/CT, (18)F-FDG PET\/CT, and (123)I-MIBG SPECT: A Study of Patients Being Evaluated for Pheochromocytoma","volume":"48","author":"Hadi","year":"2007","journal-title":"J Nucl Med"},{"key":"B75","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13550-021-00747-0","article-title":"The Role of [(68) Ga]Ga-DOTATATE PET\/CT in Wild-Type KIT\/PDGFRA Gastrointestinal Stromal Tumours (GIST)","volume":"11","author":"Aloj","year":"2021","journal-title":"EJNMMI Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-019-02274-y","article-title":"Role of 18F-FDG PET\/CT in Restaging and Follow-Up of Patients With GIST","volume":"45","author":"Albano","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11906-021-01150-9","article-title":"Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients","volume":"23","author":"Seamon","year":"2021","journal-title":"Curr Hypertens Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11864-020-00787-z","article-title":"Emerging Treatments for Advanced\/Metastatic Pheochromocytoma and Paraganglioma","volume":"21","author":"Ilanchezhian","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-3703","article-title":"High-Specific-Activity-(131)I-MIBG Versus (177)Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma","volume":"27","author":"Jha","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s13139-019-00629-3","article-title":"Role of (68)Ga-DOTATATE PET\/CT in a Case of SDHB-Related Pterygopalatine Fossa Paraganglioma Successfully Controlled With Octreotide","volume":"54","author":"Jha","year":"2020","journal-title":"Nucl Med Mol Imaging"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110051","article-title":"Belzutifan, a Potent HIF2alpha Inhibitor, in the Pacak-Zhuang Syndrome","volume":"385","author":"Kamihara","year":"2021","journal-title":"N Engl J Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2013-0369","article-title":"Counseling Patients With Succinate Dehydrogenase Subunit Defects: Genetics, Preventive Guidelines, and Dealing With Uncertainty","volume":"27","author":"Raygada","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00127","article-title":"Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma","volume":"5","author":"Mweempwa","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in Children With Inoperable Plexiform Neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.936178\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T05:27:56Z","timestamp":1657603676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.936178\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":84,"alternative-id":["10.3389\/fendo.2022.936178"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.936178","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"article-number":"936178"}}